Radiation recall dermatitis following adjuvant capecitabine in breast cancer: A case report

Authors

  • Dhiru Talukdar
  • Partha Pratim Medhi
  • Prashasti Sharma
  • Hafizul Pathan
  • Pincy Deka
  • Shasikiran Nuthalapati
  • Dhruba Jyoti Das

DOI:

https://doi.org/10.32677/ijcr.v9i10.4100

Keywords:

Capecitabine, Dermatitis, Radiation recall dermatitis, Triple-negative breast cancer

Abstract

Radiation recall dermatitis (RRD) is an acute inflammation of the skin, i.e., produced by drugs, most commonly chemotherapeutic treatments, in an area of the body that has been treated with radiation in the past. This case report describes the clinical experience of a triple-negative breast cancer patient who developed RRD after postoperative radiotherapy following adjuvant capecitabine treatment. The timing of chemotherapy after radiation therapy and the improvement in radiation dermatitis following capecitabine avoidance suggest that the reaction was a true radiation recall phenomenon.

Downloads

Download data is not yet available.

Author Biographies

  • Partha Pratim Medhi

     

     

  • Prashasti Sharma

     

     

  • Hafizul Pathan

     

     

  • Pincy Deka

     

     

  • Shasikiran Nuthalapati

     

     

  • Dhruba Jyoti Das

     

     

Downloads

Published

2024-02-01

Issue

Section

Case Report

How to Cite

Radiation recall dermatitis following adjuvant capecitabine in breast cancer: A case report. (2024). Indian Journal of Case Reports, 9(10), 293-295. https://doi.org/10.32677/ijcr.v9i10.4100

Most read articles by the same author(s)

<< < 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 > >>